80. Resistance to thyroid hormone Clinical trials / Disease details
Clinical trial : 1 / Drugs : 6 - (DrugBank : 3) / Drug target genes : 3 - Drug target pathways : 3
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04868045 (ClinicalTrials.gov) | April 27, 2021 | 28/4/2021 | Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer | Evaluation of The Development of Central Resistance to Thyroid Hormone After Prolonged Exposure to Excess Thyroid Hormone in Thyroid Cancer Patients | Thyroid Cancer | Drug: Thyrotropin Releasing Hormone (TRH);Drug: levothyroxine;Other: Hypothyroidism QOL questionnaire | Memorial Sloan Kettering Cancer Center | NULL | Recruiting | 18 Years | N/A | All | 16 | Phase 1 | United States |